These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3581712)

  • 21. Diagnosis and treatment of venous thromboembolism by consultants in Scotland.
    Prentice AG; Lowe GD; Forbes CD
    Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):630-2. PubMed ID: 6819041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged hospitalization because of inappropriate delay of warfarin therapy in deep venous thrombosis.
    Westblom TU; Marienfeld RD
    South Med J; 1985 Oct; 78(10):1164-7. PubMed ID: 4049032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose heparin therapy in the long-term management of venous thromboembolism.
    Bynum LJ; Wilson JE
    Am J Med; 1979 Oct; 67(4):553-6. PubMed ID: 386791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
    Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP;
    Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.
    Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G
    Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review.
    Swann KW; Black PM
    J Neurosurg; 1984 Dec; 61(6):1055-62. PubMed ID: 6389785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation.
    Nielsen HK; Husted SE; Krusell LR; Fasting H; Charles P; Hansen HH
    J Intern Med; 1994 May; 235(5):457-61. PubMed ID: 8182402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
    Wilbur J; Shian B
    Am Fam Physician; 2017 Mar; 95(5):295-302. PubMed ID: 28290648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin therapy for venous thrombosis and pulmonary embolism.
    Raskob GE; Carter CJ; Hull RD
    Blood Rev; 1988 Dec; 2(4):251-8. PubMed ID: 3061531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using anticoagulants safely. Guidelines for therapeutic and prophylactic regimens.
    Dhami MS; Bona RD
    Postgrad Med; 1991 Jul; 90(1):121-2, 127-32. PubMed ID: 1883410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.
    Astermark J; Björgell O; Lindén E; Lethagen S; Nilsson P; Berntorp E
    J Intern Med; 1998 Jul; 244(1):79-82. PubMed ID: 9698028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolic disease: diagnosis and use of antithrombotic therapy.
    Hyers TM
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI23-8. PubMed ID: 2191812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy.
    Clarke-Pearson DL; Synan IS; Creasman WT
    Am J Obstet Gynecol; 1983 Oct; 147(4):369-75. PubMed ID: 6624807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
    N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.